Genetic Analysis AS: Publication of Q1 report January – March 2024
OSLO, NORWAY – May 29, 2024: Today, Microbiome DX company Genetic Analysis AS ("GA" or the "Company") hereby publishes the interim report for the period January 1 – March 31, 2024. The interim report is available as an attached file to this release and on the Company's website. Below is a summary of the report.Ronny Hermansen, CEO of Genetic Analysis, comments:“During Q1 2024, GA has continued to onboard new laboratory customers by implementing the GA-map® assay on their instrument. A key objective for GA is technology implementation in laboratories since this generates recurring reagent